Ohio State sets record with $1.5 billion in R&D Funding
Photo: Ohio State
The Ohio State University’s annual research and development expenditures reached an all-time record of $1.449 billion last year, the university disclosed in its annual report of resources available to perform cutting-edge science and creative expression research. The total represents a 6% increase over Fiscal Year 2022.
Ohio State pointed to several recent successes:
Julie Johnson was recently announced as the director of the Center for Clinical and Translational Science. As director of the CCTS, Johnson is the principal investigator of a seven-year, $37.9 million Clinical and Translation Science Award from the National Institutes of Health, which funds the center’s work to turn scientific discoveries into clinical therapies.
NSF awarded $5 million to researchers at Ohio State as the lead institution, co-funded with an additional $3.75 million from the Natural Sciences and Engineering Research Council of Canada, studying the use of artificial intelligence to help understand climate impacts on biodiversity. The AI and Biodiversity Change (ABC) Global Climate Center will bring together ecologists and computer scientists from six universities in the United States and Canada, with partners in the UK, Europe and Australia, to develop new AI-enabled, data-supported approaches to study how changes in climate are impacting life – including animals, plants and insects – on Earth.
Ohio State, Honda, Schaeffler Americas, and state and federal leaders recently announced the creation of a new $22 million battery cell research and development center. Slated to open in April 2025, the lab will accelerate the domestic development of battery cell materials and manufacturing technologies while providing an experiential learning setting for advanced battery technology workforce development.
With a grant totaling $22 million from the National Institute of Health’s Somatic Cell Genome Editing (SCGE) program, researchers at the Innovative Genomics Institute (IGI) at UC Berkeley, Ohio State Wexner Medical Center and College of Medicine, and UC San Francisco are developing new approaches to treat multiple neurodegenerative diseases as well as clinical tests to help new CRISPR-based therapies reach patients.
What it means to Ohio
The analysis is part of Ohio State’s submission to the National Science Foundation’s Higher Education Research and Development (HERD) survey.
Ohio State ranked first in Ohio and No. 11 among all universities, slotting just behind Duke and Stanford and ahead of the University of North Carolina, Chapel Hill and Harvard. Ohio State ranked No. 7 among public universities.
What they’re saying
“Ohio State’s research community is deservedly recognized as among the best, and this record-breaking funding total highlights the university’s significant impact on our state and the world. The research conducted on our campuses changes lives for the better and is a critical part of Ohio State’s mission as a land-grant university to deliver discoveries the world needs now.”
- Ohio State President Walter “Ted” Carter Jr.
“These numbers illustrate the incredible scientific talent and creativity at Ohio State. From foundational work in materials and physics to space exploration, artificial intelligence and breakthrough therapeutics that improve lives, Ohio State is leading the way in science with impact.”
- Peter Mohler, Ohio State’s Executive Vice President for Research, Innovation and Knowledge
